Self-renewal vs. differentiation of mouse embryonic stem cells

Biology of Reproduction

Volumn 71, Issue 6, 2004, Pages 1755-1765

  O'Shea, K Sue ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Central nervous system; Developmental biology; Early development; Ectoderm; Embryo; Endoderm; Epiblast; Germ cell; Growth factors; Inner cell mass; Mesoderm; Pluripotency

Indexed keywords

GROWTH FACTOR;

ANIMAL CELL; BLASTOCYST; CELL DIFFERENTIATION; CELL RENEWAL; CELL TRANSPLANTATION; CELL TYPE; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; INNER CELL MASS; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RNA INTERFERENCE; SHORT SURVEY; STEM CELL; TECHNOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CLEAVAGE STAGE, OVUM; EMBRYO; GENES; MICE; PLURIPOTENT STEM CELLS; STEM CELLS;

ANIMALIA; MAMMALIA;

EID: 9744245280     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.104.028100     Document Type: Short Survey

References (134)

1. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981; 292:154-156.
2. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981; 78:7634-7638.
3. O'Shea KS. Directed differentiation of embryonic stem cells: genetic and epigenetic methods. Wound Rep Reg 2001; 9:443-459.
4. Smith AG. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 2001; 17:435-462.
5. Loebel DAF, Watson CM, DeYoung RA, Tam PPL. Lineage choice and differentiation in mouse embryos and embryonic stem cells. Dev Biol 2003; 264:1-14.
6. Piotrowska K, Wianny F, Pedersen RA, Zeraicka-Goetz M. Elastomeres arising from the first cleavage division have distinguishable fates in normal mouse development. Development 2001; 128:3739-3748.
7. Johnson MH, Ziomek CA. The foundation of two distinct cell lineages within the mouse morula. Cell 1981; 24:71-80.
8. Behringer RR, Wakamiya M, Tsang TE, Tam PPL. A flattened mouse embryo: leveling the playing field. Genesis 2000; 28:23-30.
9. Stanton JAL, Macgregor AB, Green DPL. Gene expression in the mouse preimplantation embryo. Reprod 2003; 125:457-468.
10. Jaenisch R. DNA methylation and imprinting: why bother? TIG 1997; 13:323-329.
11. Handyside A. Time of commitment of inside cells isolated from preimplantation mouse embryos. J Embryol Exp Zool 1978; 45:37-53.
12. Gardner RL, Brook FA. Reflections on the biology of embryonic stem (ES) cells. Int J Dev Biol 1997; 41:235-243.
13. Snow MHL. Gastrulation in the mouse: growth and regionalization of the epiblast. J Embryol Exp Morphol 1977; 42:293-303.
14. Ciemerych MA, Mesnard D, Zeraica-Goetz M. Animal and vegetal poles of the mouse egg predict the polarity of the embryonic axis, yet are non-essential for development. Development 2000; 127: 3467-3474.
15. Stanton JL, Green DPL. Meta-analysis of gene expression in mouse preimplantation embryo development. Mol Hum Reprod 2001; 7: 545-552.
16. Beddington RS. Histogenetic and neoplastic potential of different regions of the mouse embryonic egg cylinder. J Embryol Exp Morphol 1983; 75:189-204.
17. Cheng AM, Saxton TM, Sakai R, Kulkarni S, Mbamalu G, Vogel W, Tortorice CG, Cardiff RD, Cross JC, Muller WJ, Pawson T. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell 1998; 95:793-803.
18. Voss AK, Thomas T, Petrou P, Anastassiadis K, Scholer H, Gruss P. Taub nuss is a novel gene essential for the survival of pluripotent cells of early mouse embryos. Development 2000; 127:5449-5461.
19. Heyer J, Escalante-Alcade D, Lia M, Boettinger E, Edelmann W, Stewart CL, Kucherlapati R. Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. Proc Natl Acad Sci U S A 1999; 96:12595-12600.
20. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ. Blastocyst implantation depends on maternal expression of leukemia inhibitory factor. Nature 1992; 359:69-79.
21. Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N, Kishimoto T, Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A 1997; 94:3801-3804.
22. Nichols J, Chambers I, Taga T, Smith AG. Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development 2001; 128:2333-2339.
23. Niwa H, Burdon T, Chambers I, Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 1998; 12:2048-2060.
24. Pesce M, Scholer HR. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 2001; 19:271-278.
25. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003; 113:643-655.
26. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003; 113:631-642.
27. Hart AH, Hartley L, Ibrahim M, Robb L. Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev Dyn 2004; 230:187-198.
28. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003; 17:126-140.
29. Hanna LA, Foreman RK, Tarasenko IA, Kessler DS, Labosky PA. Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo. Genes Dev 2002; 16:2650-2661.
30. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 2004; 10:55-63.
31. Ying Q-L, Nichols J, Chambers I, Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003; 115:281-292.
32. Tanaka TS, Kunath T, Kimber WL, Jaradat SA, Stagg CA, Usuda M, Yokota T, Niwa H, Rossant J, Ko MS. Gene expression profiling of embryo-derived stem cells reveals candidate genes associated with pluripotency and lineage specificity. Genome Res 2002; 12:1921-1928.
33. Scholer HR, Dressler GR, Balling R, Rohdewohld H, Gruss P. Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBO J 1990; 9:2185-2195.
34. Palmieri SL, Peter W, Hess H, Scholer HR. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev Biol 1994; 166:259-267.
35. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct-4. Cell 1998; 95:379-391.
36. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 2003; 63:2244-2250.
37. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 2000; 24:372-376.
38. Velkey JM, O'Shea KS. Oct4 RNA interference induces trophectoderm differentiation in mouse embryonic stem cells. Genesis 2003; 37:18-24.
39. Sen G, Wehrman TS, Myers JW, Blau HM. Restriction enzyme-generated siRNA (REGS) vectors and libraries. Nat Genet 2004; 36: 183-189.
40. Du Z-W, Cong H-C, Yao Z. Identification of putative downstream genes of Oct-4 by suppression-subtractive hybridization. Biochem Biophys Res Comm 2001; 282:701-706.
41. Botquin V, Hess H, Fuhrmann G, Anastassiadis C, Gross MK, Vriend G, Scholer HR. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev 1998; 12:2073-2090.
42. Yuan H, Corbi N, Basilico C, Dailey L. Developmental-specific activity of the FGF-4 enhancer requires the synergistic action of Sox2 and Oct-3. Genes Dev 1995; 9:2635-2645.
43. Tokuzawa Y, Kaiho E, Maruyama M, Takahashi K, Mitsui K, Maeda M, Niwa H, Yamanaka S. Fbx15 is a novel target of Oct3/4 but is dispensable for embryonic stem cell self-renewal and mouse development. Mol Cell Biol 2003; 23:2699-2708.
44. Ben-Shushan E, Thompson JR, Gudas LJ, Bergman Y. Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site. Mol Cell Biol 1998; 18:1866-1878.
45. Schoorlemmer J, van Puijenbroek A, van Den Eijnden M, Jonk L, Pals C, Kruijer W. Characterization of a negative retinoic acid response element in the murine Oct4 promoter. Mol Cell Biol 1994; 14:1122-1136.
46. Yeom YI, Fuhrmann G, Ovitt CE, Brehm A, Ohbo K, Gross M, Hubner K, Scholer HR. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 1996; 122:881-894.
47. Fuhrmann G, Chung AC-K, Jackson KJ, Hummelke G, Baniahmad A, Sutter J, Sylvester I, Scholer HR, Cooney AJ. Mouse germline restriction of Oct4 expression by germ cell nuclear factor. Dev Cell 2001; 1:377-387.
48. Hubner K, Fuhrmann G, Christenson LK, Kehler J, Reinbold R, De La Fuente R, Wood J, Strauss JF III, Boiani M, Scholer HR. Derivation of oocytes from mouse embryonic stem cells. Science 2003; 300:1251-1256.
49. Nishimoto M, Fukushima A, Okuda A, Muramatsu M. The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2. Mol Cell Biol 1999; 19:5453-5465.
50. Guo Y, Costa R, Ramsey H, Starnes T, Vance G, Robertson K, Kelley M, Reinbold R, Scholer H, Hromas R. The embryonic stem cell transcription factors Oct4 and FoxD3 interact to regulate endodermal-specific promoter expression. Proc Natl Acad Sci U S A 2002; 99:3663-3667.
51. Shimozaki K, Nakashima K, Niwa H, Taga T. Involvement of Oct3/4 in the enhancement of neuronal differentiation of embryonic stem cells in neurogenesis inducing cultures. Development 2003; 130: 2505-2512.
52. Reim G, Brand M. Spiel-ohne-grenzen/pou2 mediates regional competence to respond to Fgf8 during Zebrafish early neural development. Development 2002; 129:917-933.
53. Yang X, Li C, Xu X, Deng C. The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad Sci U S A 1998; 95:3667-3672.
54. Sutton J, Costa R, Klug M, Field L, Xu D, Largaespada DA, Fletcher CF, Jenkins NA, Copeland NG, Klemsz M, Hromas R. Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells. J Biol Chem 1996; 271:23126-23133.
55. Hromas R, Ye H, Spinella M, Dmitrovsky E, Xu D, Costa RH. Genesis, a winged helix transcriptional repressor, has embryonic expression limited to the neural crest, and stimulates proliferation in vitro in a neural development model. Cell Tiss Res 1999; 297: 371-382.
56. Ambrosetti D-C, Basilico C, Dailey L. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites. Mol Cell Biol 1997; 17: 6321-6329.
57. Graham V, Khudyakov J, Ellis P, Pevny L. SOX2 functions to maintain neural progenitor identity. Neuron 2003; 39:749-765.
58. Tanaka S, Kunath T, Hadjantonakis AK, Nagy A, Rossant J. Promotion of trophoblast stem cell proliferation by FGF4. Science 1998; 282:2072-2075.
59. Rathjen J, Lake JA, Bettess MD, Washington JM, Chapman G, Rathjen PD. Formation of a primitive ectoderm like cell population, EPL cells, from ES cells in response to biologically derived factors. J Cell Sci 1999; 112:601-612.
60. Rathjen J, Haines BP, Hudson KM, Nesci A, Dunn S, Rathjen PD. Directed differentiation of pluripotent cells to neural lineages: homogeneous formation and differentiation of a neurectoderm population. Development 2002; 129:2649-2661.
61. Rodda SJ, Kavanagh SJ, Rathjen J, Rathjen PD. Embryonic stem cell differentiation and the analysis of mammalian development. Int J Dev Biol 2002; 46:449-458.
62. Lake J, Rathjen J, Remiszewski J, Rathjen PD. Reversible programming of pluripotent cell differentiation. J Cell Sci 2000; 113:555-566.
63. Pelton TA, Sharma S, Schulz TC, Rathjen J, Rathjen PD. Transient pluripotent cell populations during primitive ectoderm formation: correlation of in vivo and in vitro pluripotent cell development. J Cell Sci 2002; 115:329-339.
64. Johansson BM, Wiles MV. Evidence for involvement of Activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol Cell Biol 1995; 15:141-151.
65. Geijsen N, Horoschak M, Kim K, Gribnau J, Eggan K, Daley GQ. Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature 2004; 427:148-154.
66. Toyooka Y, Tsunekawa N, Akasu R, Noce T. Embryonic stem cells can form germ cells in vitro. Proc Natl Acad Sci U S A 2003; 20: 11457-11462.
67. Beddington RS, Robertson EJ. Axis development and early symmetry in mammals. Cell 1999; 96:195-209.
68. Tuladhar R, Patole SK, Whitehall JS. Sacrococcygeal teratomas in the perinatal period. Postgrad Med J 2000; 76:754-759.
69. Sulik K, Dehart DB, Iangaki T, Carson JL, Vrablic T, Gesteland K, Schoenwolf GC. Morphogenesis of the murine node and notochordal plate. Dev Dyn 1994; 201:260-278.
70. Wiles MV, Johansson BM. Embryonic stem cell development in a chemically defined medium. Exp Cell Res 1999; 247:241-248.
71. Fujikura J, Yamato E, Yonemura S, Hosoda K, Masui S, Nakao K, Miyazaki JJ, Niwa H. Differentiation of embryonic stem cells is induced by GATA factors. Genes Dev 2002; 16:784-789.
72. Winnier G, Blessing M, Labosky PA, Hogan BL. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995; 9:2105-2116.
73. Tropepe V, Hitoshi S, Sirard C, Mak TW, Rossant J, van der Kooy D. Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 2001; 30:65-78.
74. Finley MF, Devata S, Huettner JE. BMP-4 inhibits neural differentiation of murine embryonic stem cells. J Neurobiol 1999; 40:271-287.
75. Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, Nishikawa SI, Sasai Y. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000; 28:31-40.
76. Yoshikawa Y, Fujimori T, McMahon AP, Takada S. Evidence that absence of Wnt3a signaling promotes neuralization instead of paraxial mesoderm development in the mouse. Dev Biol 1997; 183: 234-242.
77. Yamaguchi TP, Takada S, Yoshikawa Y, Wu N, McMahon AP. T (Brachyury) is a direct target of Wnt3a during paraxial mesoderm specification. Genes Dev 1999; 13:3185-3190.
78. Ciruna BG, Schwartz L, Harpal K, Yamaguchi TP, Rossant J. Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. Development 1997; 124:2829-2841.
79. Ciruna B, Rossant J. FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev Cell 2001; 1:37-49.
80. Wilder PJ, Kelly D, Brigman K, Peterson CL, Nowling T, Gao QS, McComb RD, Capecchi MR, Rizzino A. Inactivation of the FGF-4 gene in embryonic stem cells alters the growth and/or the survival of their early differentiated progeny. Dev Biol 1997; 192:614-629.
81. Burdsal CA, Flannery ML, Pedersen RA. FGF-2 alters the fate of mouse epiblast from ectoderm to mesoderm in vitro. Dev Biol 1998; 198:231-244.
82. Robb L, Hartley L, Begley CG, Brodnicki TC, Copeland NG, Gilbert DJ, Jenkins NA, Elefanty AG. Cloning, expression analysis, and chromosomal localization of murine and human homologues of a Xenopus mix gene. Dev Dyn 2000; 219:497-504.
83. Hart AH, Hartley L, Sourris K, Stadler ES, Li R, Stanley EG, Tam PP, Elefanty AG, Robb L. Mixl1 is required for axial mesendoderm morphogenesis and patterning in the murine embryo. Development 2002; 129:3597-3608.
84. Mountford P, Nichols J, Zevnik B, O'Brien C, Smith A. Maintenance of pluripotential embryonic stem cells by stem cell selection. Reprod Fertil Dev 1998; 10:527-533.
85. Levinson-Dushnik M, Benvenisty N. Involvement of hepatocyte nuclear factor 3 in endoderm differentiation of embryonic stem cells. Mol Cell Biol 1997; 17:3817-3822.
86. Coucouvanis E, Martin GR. Signals for death and survival: a two-step mechanism for cavitation in the vertebrate embryo. Cell 1995; 83:279-287.
87. Kanai-Azuma M, Kanai Y, Gad JM, Tajima Y, Taya C, Kurohmaru M, Sanai Y, Yonekawa H, Yazaki K, Tam PP, Hayashi Y. Depletion of definitive gut endoderm in Sox17-null mutant mice. Development 2002; 129:2367-2379.
88. Lickert H, Kutsch S, Kanzler B, Tamai Y, Taketo MM, Kemler R. Formation of multiple hearts in mice following deletion of β-catenin in the embryonic endoderm. Dev Cell 2002; 3:171-181.
89. Gratsch TE, O'Shea KS. Noggin and chordin have distinct activities in promoting lineage commitment of mouse embryonic stem (ES) cells. Dev Biol 2002; 245:83-94.
90. Aubert J, Dunstan H, Chambers I, Smith A. Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation. Nat Biotechnol 2002; 20:1240-1245.
91. Haegele L, Ingold B, Naumann H, Tabatabai G, Ledermann B, Brandner S. Wnt signaling inhibits neural differentiation of embryonic stem cells by controlling bone morphogenetic protein expression. Mol Cell Neurosci 2003; 24:696-708.
92. Kielman MF, Rindapaa M, Caspar C, van Poppel N, Breukel C, van Leeuwen S, Taketo MM, Roberts S, Smits R, Fodde R. Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signaling. Nat Genet 2002; 32:594-605.
93. Niswander I, Martin GR. Fgf-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. Development 1992; 114:755-768.
94. Feldman B, Poueymirou W, Papaioannou VE, DeChiara TM, Goldfarb M. Requirement of FGF-4 for postimplantation mouse development. Science 1995; 267:246-249.
95. Ying Q-L, Stavridis M, Griffiths D, Li M, Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 2003; 21:183-186.
96. Sheng G, dos Reis M, Stern CD. Churchill, a zinc finger transcriptional activator, regulates the transition between gastrulation and neurulation. Cell 2003; 115:603-613.
97. van de Putte T, Maruhashi M, Francis A, Nelles L, Kondoh H, Huylebroeck D, Higashi Y. Mice lacking ZFHX1B, the gene that codes for Smad-interacting protein-1, reveal a role for multiple neural crest cell defects in the etiology of Hirschsprung disease-mental retardation syndrome. Am J Hum Genet 2003; 72:465-470.
98. Kroll KL, Salic AN, Evans LM, Kirschner MW. Geminin, a neuralizing molecule that demarcates the future neural plate at the onset of gastrulation. Development 1998; 125:3247-3258.
99. Keller GM. In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol 1995; 7:862-869.
100. Martin GR, Evans MJ. Multiple differentiation of clonal teratocarcinoma stem cells following embryoid body formation in vitro. Cell 1975; 6:467-474.
101. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morph 1985; 87:27-45.
102. Leahy A, Xiong J-W, Kuhnert F, Stuhlmann H. Use of developmental marker genes to define temporal and spatial patterns of differentiation during embryoid body formation. J Exp Zool 1999; 284:67-81.
103. Rathjen PD, Toth S, Willis A, Heath JK, Smith AG. Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell 1990; 62: 1105-1114.
104. Maye P, Becker S, Siemen H, Thorne J, Byrd N, Carpentino J, Grabel L. Hedgehog signaling is required for the differentiation of ES cells into neuroectoderm. Dev Biol 2004; 265:276-290.
105. Walsh J, Andrews PW. Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cells. APMIS 2003; 111:197-211.
106. Fair JH, Cairns BA, LaPaglia M, Wang J, Meyer AA, Kim H, Hatada S, Smithies O, Pevny L. Induction of hepatic differentiation in embryonic stem cells by coculture with embryonic cardiac mesoderm. Surgery 2003; 134:189-196.
107. Barberi T, Klivenyi P, Calingasan NY, Lee H, Kawamata H, Loonam K, Perrier AL, Bruses J, Rubio ME, Topf N, Tabar V, Harrison NL, Flint-Beal M, Moore MAS, Studer L. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotech 2003; 21:1200-1207.
108. Wichterle H, Lieberam I, Porter JA, Jessell TM. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002; 110: 385-397.
109. Friedrich G, Soriano P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev 1991; 5:1513-1523.
110. Stanford WL, Caruana G, Vallis KA, Inamdar M, Hidaka M, Bautch VL, Bernstein A. Expression trapping: identification of novel genes expressed in hematopoietic and endothelial lineages by gene trapping in ES cells. Blood 1998; 92:4622-4631.
111. Skarnes WC. Gene trapping methods for the identification and functional analysis of cell surface proteins in mice. Methods Enzymol 2000; 328:592-615.
112. Forrester LM, Nagy A, Sam M, Watt A, Stevenson L, Bernstein A, Joyner AL, Wurst W. An induction gene trap screen in embryonic stem cells: identification of genes that respond to retinoic acid in vitro. Proc Natl Acad Sci U S A 1996; 93:1677-1682.
113. Hadjantonakis AK, Macmaster S, Nagy A. ES cells and mice expressing different GFP variants for multiple non-invasive reporter usage within a single animal. BMC Biotech 2002; 2:11.
114. Wernig M, Tucker KL, Gornik V, Schneiders A, Buschwald R, Wiestler OD, Bard YA, Brustle O. Tau EGFP embryonic stem cells: an efficient tool for neuronal lineage selection and transplantation. J Neurosci Res 2002; 69:918-924.
115. Li M, Pevny L, Lovell-Badge R, Smith A. Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol 1998; 8:971-974.
116. Fehling HJ, Lacaud G, Kubo A, Kennedy M, Robertson S, Keller G, Kouskoff V. Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 2003; 130:4217-4227.
117. Tucker KL, Meyer M, Barde YA. Neurotrophins are required for nerve growth during development. Nat Neurosci 2001; 4:29-37.
118. Lenka N, Lu ZJ, Sasse P, Hescheler J, Fleischmann BK. Quantitation and functional characterization of neural cells derived from ES cells using nestin enhancer-mediated targeting in vitro. J Cell Sci 2002; 115:1471-1485.
119. Klug MG, Soonpaa MH, Koh GY, Field LJ. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J Clin Invest 1996; 98:216-224.
120. Soria B, Roche E, Berna G, Leon-Quinto T, Reig JA, Martin F. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes 2000; 49: 157-162.
121. Xian HQ, McNichols E, St. Clair A, Gottlieb DI. A subset of ES-cell-derived neural cells marked by gene targeting. Stem Cells 2003; 21:41-49.
122. Gassmann M, Donoho G, Berg P. Maintenance of an extra-chromosomal plasmid vector in mouse embryonic stem cells. Proc Natl Acad Sci U S A 1995; 92:1292-1296.
123. Kyba M, Perlingeiro RC, Daley GQ. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 2002; 109:29-37.
124. Fareed MU, Moolten FL. Suicide gene transduction sensitizes murine embryonic and human mesenchymal stem cells to ablation on demand-a fail-safe protection against cellular misbehavior. Gene Ther 2002; 9:955-962.
125. Houbaviy HB, Murray MF, Sharp PA. Embryonic stem cell-specific microRNAs. Dev Cell 2003; 5:351-358.
126. Chen Y, Yee D, Dains K, Chatterjee A, Cavalcoli J, Schneider E, Om J, Woychik RP, Magnuson T. Genotype-based screen for ENU-induced mutations in mouse embryonic stem cells. Nat Genet 2000; 24:314-317.
127. Sato N, Sanjuan IM, Heke M, Uchida M, Naef F, Brivanlou AH. Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev Biol 2003; 260:404-413.
128. Yang S, Tutton S, Pierce E, Yoon K. Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol Cell Biol 2001; 21:7807-7816.
129. Abe Y, Kouyama K, Tomita T, Tomita Y, Ban N, Nawa M, Matsuoka M, Niikura T, Aiso S, Kita Y, Iwatsubo T, Nishimoto I. Analysis of neurons created from wild-type and Alzheimer's mutation knock-in embryonic stem cells by a highly efficient differentiation protocol. J Neurosci 2003; 23:8513-8525.
130. Lorincz MT, Detloff PJ, Albin RL, O'Shea KS. Embryonic stem cells expressing expanded CAG repeats undergo aberrant neuronal differentiation and have persistent Oct-4 and REST/NRSF expression. Mol Cell Neurosci 2004; 26:(1)135-143.
131. Thomas KR, Capecchi MR. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987; 51:503-512.
132. Sligh JE, Levy SE, Waymire KG, Allard P, Dillehay DL, Nusinowitz S, Heckenlively JR, MacGregor GR, Wallace DC. Maternal germline transmission of mutant mtDNAs from embryonic stem cell-derived chimeric mice. Proc Natl Acad Sci U S A 2000; 97:14461-14466.
133. Hernandez D, Mee PJ, Martin JE, Tybulewicz VLJ, Fisher EMC. Transchromosomal mouse embryonic stem cell lines and chimeric mice that contain freely segregating segments of human chromosome 21. Hum Mol Genet 1999; 8:923-933.
134. Wutz A, Jaenisch R. A shift from reversible to irreversible X inactivation is triggered during ES cell differentiation. Mol Cell 2000; 5: 695-705.